Resultats de la cerca - Lushan Yu

  • Mostrar 1 - 12 resultats de 12
Refinar resultats
  1. 1
    Stereoselective binding of chiral drugs to plasma proteins

    Stereoselective binding of chiral drugs to plasma proteins per Qi Shen, Lu Wang, Hui Zhou, Huidi Jiang, Lushan Yu, Su Zeng

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy

    Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy per Quan Zhou, Meng Chen, Lingling Zhu, Lushan Yu, Su Zeng, Mei Xiang, Zhiyu Wang

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Research and development of drug delivery systems based on drug transporter and nano-formulation

    Research and development of drug delivery systems based on drug transporter and nano-formulation per Yi Peng, Lu Chen, Sheng Ye, Yu Kang, Junqing Liu, Su Zeng, Lushan Yu

    Publicat 2020
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents

    The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents per Jiabei Zhou, Yu Kang, Lu Chen, Hua Wang, Junqing Liu, Su Zeng, Lushan Yu

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Regulation mechanism of endoplasmic reticulum stress on metabolic enzymes in liver diseases

    Regulation mechanism of endoplasmic reticulum stress on metabolic enzymes in liver diseases per Shaojun Zhou, Kaiwen Cheng, Yi‐Jen Peng, Yuxi Liu, Qingqing Hu, Su Zeng, Xuchen Qi, Lushan Yu

    Publicat 2024
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2

    Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2 per Lu Chen, Le Chen, Zhiyuan Qin, Jinxiu Lei, Ye Sheng, Kui Zeng, Hua Wang, Meidan Ying, Jianqing Gao, Su Zeng, Lushan Yu

    Publicat 2019
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    VARIDT 3.0: the phenotypic and regulatory variability of drug transporter

    VARIDT 3.0: the phenotypic and regulatory variability of drug transporter per Jiayi Yin, Zhen Chen, Nanxin You, Fengcheng Li, Hanyu Zhang, Xue Jia, Hui Ma, Qingwei Zhao, Lushan Yu, Su Zeng, Feng Zhu

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    KLF4 functions as an oncogene in promoting cancer stem cell-like characteristics in osteosarcoma cells

    KLF4 functions as an oncogene in promoting cancer stem cell-like characteristics in osteosarcoma cells per Xiaotian Qi, Yang-ling Li, Yanqi Zhang, Tong Xu, Bin Lü, Liang Fang, Jianqing Gao, Lushan Yu, Difeng Zhu, Bo Yang, Qiaojun He, Meidan Ying

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Bi-targeting of thioredoxin 1 and telomerase by thiotert promotes cell death of myelodysplastic syndromes and lymphoma

    Bi-targeting of thioredoxin 1 and telomerase by thiotert promotes cell death of myelodysplastic syndromes and lymphoma per Qiangan Jing, Yunyi Wu, Yanchun Li, Chaoting Zhou, Junyu Zhang, Jun Xia, Keyi Li, Yuhuan Shen, Hongfeng Yao, Xiangmin Tong, Jing Du, Lushan Yu, Ying Wang

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    INTEDE: interactome of drug-metabolizing enzymes

    INTEDE: interactome of drug-metabolizing enzymes per Jiayi Yin, Fengcheng Li, Ying Zhou, Minjie Mou, Yinjing Lu, Kangli Chen, Xue Jia, Yongchao Luo, Jianbo Fu, Xu He, Jianqing Gao, Su Zeng, Lushan Yu, Feng Zhu

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    VARIDT 2.0: structural variability of drug transporter

    VARIDT 2.0: structural variability of drug transporter per Tingting Fu, Fengcheng Li, Yang Zhang, Jiayi Yin, Wenqi Qiu, Xuedong Li, Xingang Liu, Wenwen Xin, Chengzhao Wang, Lushan Yu, Jianqing Gao, Qing‐Chuan Zheng, Su Zeng, Feng Zhu

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    VARIDT 1.0: variability of drug transporter database

    VARIDT 1.0: variability of drug transporter database per Jiayi Yin, Wen Sun, Fengcheng Li, Jiajun Hong, Xiaoxu Li, Ying Zhou, Yinjing Lu, Mengzhi Liu, Xue Zhang, Na Chen, Xiuping Jin, Xue Jia, Su Zeng, Lushan Yu, Feng Zhu

    Publicat 2019
    Obtenir text complet
    Errata/Corrigenda
    Afegir a favorits
    Guardat en:

Eines de cerca: